These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11087898)

  • 21. Mutations induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the lacZ and cII genes of Muta Mouse.
    Hashimoto K; Ohsawa K; Kimura M
    Mutat Res; 2004 Jun; 560(2):119-31. PubMed ID: 15157650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice.
    Davis CD; Dacquel EJ; Schut HA; Thorgeirsson SS; Snyderwine EG
    Mutat Res; 1996 Sep; 356(2):287-96. PubMed ID: 8841498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cII locus in the MutaMouse system.
    Swiger RR; Cosentino L; Shima N; Bielas JH; Cruz-Munoz W; Heddle JA
    Environ Mol Mutagen; 1999; 34(2-3):201-7. PubMed ID: 10529745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the mutational spectra of the lacZ transgene in four organs of the MutaMouse treated with benzo[a]pyrene: target organ specificity.
    Hakura A; Tsutsui Y; Sonoda J; Tsukidate K; Mikami T; Sagami F
    Mutat Res; 2000 Feb; 447(2):239-47. PubMed ID: 10751607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
    Knöll A; Jacobson DP; Kretz PL; Lundberg KS; Short JM; Sommer SS
    Mutat Res; 1994 Nov; 311(1):57-67. PubMed ID: 7526175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline.
    Bol SA; Horlbeck J; Markovic J; de Boer JG; Turesky RJ; Constable A
    Carcinogenesis; 2000 Jan; 21(1):1-6. PubMed ID: 10607726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2005; 291():145-53. PubMed ID: 15502219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations that alter the DNA binding site for the bacteriophage lambda cII protein and affect the translation efficiency of the cII gene.
    Place N; Fien K; Mahoney ME; Wulff DL; Ho YS; Debouck C; Rosenberg M; Shih MC; Gussin GN
    J Mol Biol; 1984 Dec; 180(4):865-80. PubMed ID: 6241264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in the liver and bone marrow of lacI transgenic mice.
    Ushijima T; Hosoya Y; Ochiai M; Kushida H; Wakabayashi K; Suzuki T; Hayashi M; Sofuni T; Sugimura T; Nagao M
    Carcinogenesis; 1994 Dec; 15(12):2805-9. PubMed ID: 8001238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea.
    Krebs O; Favor J
    Mutat Res; 1997 Feb; 388(2-3):239-48. PubMed ID: 9057886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats.
    Mei N; Heflich RH; Chou MW; Chen T
    Chem Res Toxicol; 2004 Jun; 17(6):814-8. PubMed ID: 15206902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of mutations in transgenic fish carrying a bacteriophage lambda cII transgene target.
    Winn RN; Norris MB; Brayer KJ; Torres C; Muller SL
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12655-60. PubMed ID: 11035814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The phage lambda CII transcriptional activator carries a C-terminal domain signaling for rapid proteolysis.
    Kobiler O; Koby S; Teff D; Court D; Oppenheim AB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14964-9. PubMed ID: 12397182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of the restriction site mutation assay to compare 1-ethyl-1-nitrosourea-induced mutations between the endogenous p53 gene and the transgenic LacZ gene in MutaMouse testes.
    Song HL; Jenkins GJ; Ashby J; Tinwell H; Parry JM
    Mutagenesis; 2001 Jan; 16(1):59-64. PubMed ID: 11139599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Escherichia coli RNA polymerase alpha subunit and transcriptional activation by bacteriophage lambda CII protein.
    Gabig M; Obuchowski M; Ciesielska A; Latała B; Wegrzyn A; Thomas MS; Wegrzyn G
    Acta Biochim Pol; 1998; 45(1):271-80. PubMed ID: 9701520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.